These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 16835228

  • 1. Antitumorigenic effect of Wnt 7a and Fzd 9 in non-small cell lung cancer cells is mediated through ERK-5-dependent activation of peroxisome proliferator-activated receptor gamma.
    Winn RA, Van Scoyk M, Hammond M, Rodriguez K, Crossno JT, Heasley LE, Nemenoff RA.
    J Biol Chem; 2006 Sep 15; 281(37):26943-50. PubMed ID: 16835228
    [Abstract] [Full Text] [Related]

  • 2. Restoration of Wnt-7a expression reverses non-small cell lung cancer cellular transformation through frizzled-9-mediated growth inhibition and promotion of cell differentiation.
    Winn RA, Marek L, Han SY, Rodriguez K, Rodriguez N, Hammond M, Van Scoyk M, Acosta H, Mirus J, Barry N, Bren-Mattison Y, Van Raay TJ, Nemenoff RA, Heasley LE.
    J Biol Chem; 2005 May 20; 280(20):19625-34. PubMed ID: 15705594
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Sprouty-4 inhibits transformed cell growth, migration and invasion, and epithelial-mesenchymal transition, and is regulated by Wnt7A through PPARgamma in non-small cell lung cancer.
    Tennis MA, Van Scoyk MM, Freeman SV, Vandervest KM, Nemenoff RA, Winn RA.
    Mol Cancer Res; 2010 Jun 20; 8(6):833-43. PubMed ID: 20501643
    [Abstract] [Full Text] [Related]

  • 5. Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaB.
    Bren-Mattison Y, Meyer AM, Van Putten V, Li H, Kuhn K, Stearman R, Weiser-Evans M, Winn RA, Heasley LE, Nemenoff RA.
    Mol Pharmacol; 2008 Mar 20; 73(3):709-17. PubMed ID: 18055759
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancer.
    Avasarala S, Bikkavilli RK, Van Scoyk M, Zhang W, Lapite A, Hostetter L, Byers JT, Heasley LE, Sohn JW, Winn RA.
    PLoS One; 2013 Mar 20; 8(10):e76895. PubMed ID: 24204697
    [Abstract] [Full Text] [Related]

  • 8. Increased Wnt5a in squamous cell lung carcinoma inhibits endothelial cell motility.
    Rapp J, Kiss E, Meggyes M, Szabo-Meleg E, Feller D, Smuk G, Laszlo T, Sarosi V, Molnar TF, Kvell K, Pongracz JE.
    BMC Cancer; 2016 Nov 23; 16(1):915. PubMed ID: 27876017
    [Abstract] [Full Text] [Related]

  • 9. The Frizzled family of unconventional G-protein-coupled receptors.
    Schulte G, Bryja V.
    Trends Pharmacol Sci; 2007 Oct 23; 28(10):518-25. PubMed ID: 17884187
    [Abstract] [Full Text] [Related]

  • 10. Peroxisome proliferator-activated receptor-gamma ligands inhibit alpha5 integrin gene transcription in non-small cell lung carcinoma cells.
    Han S, Rivera HN, Roman J.
    Am J Respir Cell Mol Biol; 2005 Apr 23; 32(4):350-9. PubMed ID: 15677767
    [Abstract] [Full Text] [Related]

  • 11. Combined treatment with peroxisome proliferator-activated receptor (PPAR) gamma ligands and gamma radiation induces apoptosis by PPARγ-independent up-regulation of reactive oxygen species-induced deoxyribonucleic acid damage signals in non-small cell lung cancer cells.
    Han EJ, Im CN, Park SH, Moon EY, Hong SH.
    Int J Radiat Oncol Biol Phys; 2013 Apr 01; 85(5):e239-48. PubMed ID: 23332223
    [Abstract] [Full Text] [Related]

  • 12. Wnt signaling pathway in non-small cell lung cancer.
    Stewart DJ.
    J Natl Cancer Inst; 2014 Jan 01; 106(1):djt356. PubMed ID: 24309006
    [Abstract] [Full Text] [Related]

  • 13. Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.
    Sun X, Ritzenthaler JD, Zheng Y, Roman J, Han S.
    Mol Cancer Ther; 2009 Jan 01; 8(1):110-8. PubMed ID: 19139119
    [Abstract] [Full Text] [Related]

  • 14. Assessment of Frizzled 6 membrane mobility by FRAP supports G protein coupling and reveals WNT-Frizzled selectivity.
    Kilander MB, Dahlström J, Schulte G.
    Cell Signal; 2014 Sep 01; 26(9):1943-9. PubMed ID: 24873871
    [Abstract] [Full Text] [Related]

  • 15. Rosiglitazone suppresses human lung carcinoma cell growth through PPARgamma-dependent and PPARgamma-independent signal pathways.
    Han S, Roman J.
    Mol Cancer Ther; 2006 Feb 01; 5(2):430-7. PubMed ID: 16505118
    [Abstract] [Full Text] [Related]

  • 16. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).
    Bren-Mattison Y, Van Putten V, Chan D, Winn R, Geraci MW, Nemenoff RA.
    Oncogene; 2005 Feb 17; 24(8):1412-22. PubMed ID: 15608671
    [Abstract] [Full Text] [Related]

  • 17. Emodin Increases Expression of Insulin-Like Growth Factor Binding Protein 1 through Activation of MEK/ERK/AMPKα and Interaction of PPARγ and Sp1 in Lung Cancer.
    Tang Q, Wu J, Zheng F, Hann SS, Chen Y.
    Cell Physiol Biochem; 2017 Feb 17; 41(1):339-357. PubMed ID: 28214826
    [Abstract] [Full Text] [Related]

  • 18. AP-1 transcription factor complex is a target of signals from both WnT-7a and N-cadherin-dependent cell-cell adhesion complex during the regulation of limb mesenchymal chondrogenesis.
    Tufan AC, Daumer KM, DeLise AM, Tuan RS.
    Exp Cell Res; 2002 Feb 15; 273(2):197-203. PubMed ID: 11822875
    [Abstract] [Full Text] [Related]

  • 19. Peroxisome proliferator-activated receptor γ (PPARγ) plays a critical role in the development of TGFβ resistance of H460 cell.
    Lin LC, Hsu SL, Wu CL, Liu WC, Hsueh CM.
    Cell Signal; 2011 Oct 15; 23(10):1640-50. PubMed ID: 21664967
    [Abstract] [Full Text] [Related]

  • 20. Uncoupling protein 2 downregulation by hypoxia through repression of peroxisome proliferator-activated receptor γ promotes chemoresistance of non-small cell lung cancer.
    Wang M, Li G, Yang Z, Wang L, Zhang L, Wang T, Zhang Y, Zhang S, Han Y, Jia L.
    Oncotarget; 2017 Jan 31; 8(5):8083-8094. PubMed ID: 28042952
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.